| pubmed-article:12909809 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12909809 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:12909809 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:12909809 | lifeskim:mentions | umls-concept:C0038766 | lld:lifeskim |
| pubmed-article:12909809 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:12909809 | lifeskim:mentions | umls-concept:C1511726 | lld:lifeskim |
| pubmed-article:12909809 | lifeskim:mentions | umls-concept:C0470187 | lld:lifeskim |
| pubmed-article:12909809 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
| pubmed-article:12909809 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:12909809 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:12909809 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:12909809 | pubmed:dateCreated | 2003-8-11 | lld:pubmed |
| pubmed-article:12909809 | pubmed:abstractText | 33 years after the UGDP study, the question of deleterious effects of the sulfoylurea (SU) is still raised. We have made a systematic review of the literature from experimental studies to clinical and epidemiological studies. | lld:pubmed |
| pubmed-article:12909809 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12909809 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12909809 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12909809 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12909809 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12909809 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12909809 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12909809 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12909809 | pubmed:issn | 1262-3636 | lld:pubmed |
| pubmed-article:12909809 | pubmed:author | pubmed-author:CharpentierGG | lld:pubmed |
| pubmed-article:12909809 | pubmed:author | pubmed-author:DanchinNN | lld:pubmed |
| pubmed-article:12909809 | pubmed:author | pubmed-author:Varroud-VialM... | lld:pubmed |
| pubmed-article:12909809 | pubmed:author | pubmed-author:RivelineJ PJP | lld:pubmed |
| pubmed-article:12909809 | pubmed:author | pubmed-author:LedruFF | lld:pubmed |
| pubmed-article:12909809 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12909809 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:12909809 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12909809 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12909809 | pubmed:pagination | 207-22 | lld:pubmed |
| pubmed-article:12909809 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:12909809 | pubmed:meshHeading | pubmed-meshheading:12909809... | lld:pubmed |
| pubmed-article:12909809 | pubmed:meshHeading | pubmed-meshheading:12909809... | lld:pubmed |
| pubmed-article:12909809 | pubmed:meshHeading | pubmed-meshheading:12909809... | lld:pubmed |
| pubmed-article:12909809 | pubmed:meshHeading | pubmed-meshheading:12909809... | lld:pubmed |
| pubmed-article:12909809 | pubmed:meshHeading | pubmed-meshheading:12909809... | lld:pubmed |
| pubmed-article:12909809 | pubmed:meshHeading | pubmed-meshheading:12909809... | lld:pubmed |
| pubmed-article:12909809 | pubmed:meshHeading | pubmed-meshheading:12909809... | lld:pubmed |
| pubmed-article:12909809 | pubmed:meshHeading | pubmed-meshheading:12909809... | lld:pubmed |
| pubmed-article:12909809 | pubmed:meshHeading | pubmed-meshheading:12909809... | lld:pubmed |
| pubmed-article:12909809 | pubmed:meshHeading | pubmed-meshheading:12909809... | lld:pubmed |
| pubmed-article:12909809 | pubmed:meshHeading | pubmed-meshheading:12909809... | lld:pubmed |
| pubmed-article:12909809 | pubmed:meshHeading | pubmed-meshheading:12909809... | lld:pubmed |
| pubmed-article:12909809 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12909809 | pubmed:articleTitle | Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications. | lld:pubmed |
| pubmed-article:12909809 | pubmed:affiliation | Department of Diabetology, Sud-Francilien Hospital, Corbeil, France. jean-pierre.riveline@libertysurf.fr | lld:pubmed |
| pubmed-article:12909809 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12909809 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12909809 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12909809 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12909809 | lld:pubmed |
